Net Loss Per Share (Tables)

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 30, 2022

Sep. 30, 2022

Dec. 31, 2021

Earnings Per Share [Abstract]

Schedule of basic and diluted earnings per share

	Six Months Ended June 30, 2022
	Class A			Class B
Allocation of undistributed earnings	$	(4,396	)	$	(31,510	)
Weighted average number of shares outstanding, basic and diluted		279			2,000
Basic and diluted net loss per share of Class A and Class B common stock	$	(15.76	)	$	(15.76	)

	Six Months Ended June 30, 2021
	Class A			Class B
Allocation of undistributed earnings	$	(41	)	$	(10,332	)
Weighted average number of shares outstanding, basic and diluted		8			2,000
Basic and diluted net loss per share of Class A and Class B common stock	$	(5.17	)	$	(5.17	)

	Three Months Ended September 30, 2022			Three Months Ended September 30, 2021			Nine Months Ended September 30, 2022			Nine Months Ended September 30, 2021
Net loss available to common shares	$	(11,277	)	$	(27,241	)	$	(47,183	)	$	(37,614	)
Basic and diluted weighted average number of Class A Common Stock		6,122			5,826			5,975			5,817
Basic and diluted net loss available to Class A Common Stock	$	(1.84	)	$	(4.68	)	$	(7.90	)	$	(6.47	)

	2021
	Class A			Class B
Allocation of undistributed earnings	$	(368	)	$	(38,120	)
Weighted average number of shares outstanding, basic and diluted		19			2,000
Basic and diluted net loss per share of Class A and Class B common stock	$	(19.06	)	$	(19.06	)

	2020
Net loss	$	(8,653	)
Weighted average number of Class B common shares outstanding, basic and diluted		2,000
Basic and diluted net loss per share of Class B common stock	$	(4.33	)

Schedule of antidilutive and reduce the net loss per common stock

	Six Months Ended June 30,
	2022		2021
Series A preferred stock		8,000		8,000
2021 Bridge Debentures		6,596		3,272
2022 Bridge Debentures		6,899		—
Total warrants		3,281		3,535
Total stock options		5,106		4,448
Total antidilutive shares		29,882		19,255

	As of September 30,
	2022		2021
Series A preferred stock		-		4,646,698
2021 Bridge Debentures		-		6,759,642
2022 Bridge Debentures		-		7,810,509
Public and private warrants		10,378,750		-
Assumed warrants		1,905,853		1,905,853
Assumed options		2,965,500		2,965,500
Total antidilutive shares		15,250,103		24,088,202

	2021		2020
Series A preferred stock		8,000		8,000
Convertible debentures		3,272		—
Total warrants		3,535		—
Total stock options		4,877		—
Total antidilutive shares		19,684		8,000